IMS Institute for Healthcare Informatics

Autoimmune drug pipeline: What health execs should watchNew drugs for RA, psoriasis, type 1 diabetes and Crohn’s disease—some recently approved and others coming down the pipeline—could have an impact on the industry.
Clinical team alignment top priority for payersInvestment in resources that support clinicians and patients closer to the point of care may be the cure for what ails managed care executives.
Impossible TaskManaging the costs of specialty pharmaceuticals is a perpetual task for specialty pharmacists.
Diabetes complications fuel rising costsMedication nonadherence and complications from type 2 diabetes is resulting in signficant economic and societal burdens in the U.S. and other countries, according to a new report.
Top 5 facts about cancer drug costsThe global oncology market was worth $107 billion in 2015, and global annual cancer drug costs surged by 11.5% from 2011 to 2015, according to a new report.
Assessing the impact of biosimilars on cost, qualityA new report from IMS Institute for Healthcare Informatics finds that biosimilar acceptance will grow and drive change in the healthcare system.
Top 7 new facts about drug spendingAs organizations and politicians continue to sound the alarm that drug prices are rising, another new report confirmed the trend. Total spending on medicines in the US reached $310 billion in 2015 on an estimated net price basis, up 8.5 percent from the previous year, according to a new report from the IMS Institute for Healthcare Informatics.
Global drug spending to reach $1.4 trillionGlobal spending on medications will reach $1.4 trillion by 2020 due to greater patient access to chronic disease treatments and breakthrough innovations in drug therapies, according to a new report.
Mobile health apps should connect to EHRsWhile healthcare providers agree that mobile health apps can reduce healthcare costs and improve patient outcomes, a few barriers to full adoption remain, according to a new report.
Changing trends that may alter course of glaucoma practices